BetterLife Pharma Inc

NEW
FRA:NPAU (Canada)  
€ 0.13 -0.0010 (-0.74%) Jul 20
At Loss
Market Cap:
€ 23.08M ($ 26.34M)
Enterprise V:
€ 25.75M ($ 29.39M)
Volume:
336.00
Avg Vol (2M):
16.36K
Trade In:

Business Description

Description
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
Name Current Vs Industry Vs History
Cash-To-Debt
0.03
Equity-to-Asset
-40.2
Debt-to-Equity
-0.11
Debt-to-EBITDA
-0.6
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
69.49
9-Day RSI
72.28
14-Day RSI
73.75
3-1 Month Momentum %
-4.35
6-1 Month Momentum %
37.5
12-1 Month Momentum %
-37.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.04
Quick Ratio
0.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-19
Shareholder Yield %
0.29
Name Current Vs Industry Vs History
ROA %
-779.65
ROIC %
-150.88
3-Year ROIIC %
1315.9
Moat Score
2
Tariff Resilience Score
4

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-24
EV-to-EBITDA
-24
EV-to-FCF
-48.96
Earnings Yield (Greenblatt) %
-4.17
FCF Yield %
-2.28

Financials

FRA:NPAU's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

BetterLife Pharma Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.008
Beta 1.4286
3-Year Sharpe Ratio 0.52
3-Year Sortino Ratio 1.57
Volatility % 184.51
14-Day RSI 73.75
14-Day ATR (€) 0.00957
20-Day SMA (€) 0.101525
12-1 Month Momentum % -37.14
52-Week Range (€) 0.0175 - 0.148
Shares Outstanding (Mil) 162.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BetterLife Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

BetterLife Pharma Inc Stock Events

Financials Calendars
Event Date Price (€)
0.1:1 Stock Split 2020-06-26 1.00 (-5.24%)
Show
Entries

BetterLife Pharma Inc Frequently Asked Questions

What is BetterLife Pharma Inc(FRA:NPAU)'s stock price today?
The current price of FRA:NPAU is €0.13. The 52 week high of FRA:NPAU is €0.15 and 52 week low is €0.02.
When is next earnings date of BetterLife Pharma Inc(FRA:NPAU)?
The next earnings date of BetterLife Pharma Inc(FRA:NPAU) is .
Does BetterLife Pharma Inc(FRA:NPAU) pay dividends? If so, how much?
BetterLife Pharma Inc(FRA:NPAU) does not pay dividend.

Articles on BetterLife Pharma Inc

No articles.